[go: up one dir, main page]

GB202208160D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB202208160D0
GB202208160D0 GBGB2208160.8A GB202208160A GB202208160D0 GB 202208160 D0 GB202208160 D0 GB 202208160D0 GB 202208160 A GB202208160 A GB 202208160A GB 202208160 D0 GB202208160 D0 GB 202208160D0
Authority
GB
United Kingdom
Prior art keywords
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB2208160.8A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tay Therapeutics Ltd
Original Assignee
Tay Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tay Therapeutics Ltd filed Critical Tay Therapeutics Ltd
Priority to GBGB2208160.8A priority Critical patent/GB202208160D0/en
Priority to GB2317288.5A priority patent/GB2621505B/en
Priority to KR1020247003296A priority patent/KR20240027764A/en
Priority to CN202280047068.8A priority patent/CN117642399A/en
Priority to US18/575,006 priority patent/US20240308998A1/en
Priority to EP22737961.7A priority patent/EP4363417A1/en
Priority to AU2022303310A priority patent/AU2022303310A1/en
Priority to PCT/GB2022/051667 priority patent/WO2023275542A1/en
Priority to JP2023579060A priority patent/JP2024523491A/en
Priority to CA3224302A priority patent/CA3224302A1/en
Priority to IL309651A priority patent/IL309651A/en
Priority to MX2024000238A priority patent/MX2024000238A/en
Publication of GB202208160D0 publication Critical patent/GB202208160D0/en
Ceased legal-status Critical Current

Links

GBGB2208160.8A 2021-06-29 2022-06-01 Compounds Ceased GB202208160D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB2208160.8A GB202208160D0 (en) 2022-06-01 2022-06-01 Compounds
GB2317288.5A GB2621505B (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of inflammatory disorders, immune disorders and cancer
KR1020247003296A KR20240027764A (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer
CN202280047068.8A CN117642399A (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in treating cancer
US18/575,006 US20240308998A1 (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer
EP22737961.7A EP4363417A1 (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer
AU2022303310A AU2022303310A1 (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer
PCT/GB2022/051667 WO2023275542A1 (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer
JP2023579060A JP2024523491A (en) 2021-06-29 2022-06-29 Pyrrolopyridone Derivatives Useful in the Treatment of Cancer
CA3224302A CA3224302A1 (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer
IL309651A IL309651A (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer
MX2024000238A MX2024000238A (en) 2021-06-29 2022-06-29 Pyrrolopyridone derivatives useful in the treatment of cancer.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB2208160.8A GB202208160D0 (en) 2022-06-01 2022-06-01 Compounds

Publications (1)

Publication Number Publication Date
GB202208160D0 true GB202208160D0 (en) 2022-07-13

Family

ID=82324237

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB2208160.8A Ceased GB202208160D0 (en) 2021-06-29 2022-06-01 Compounds

Country Status (2)

Country Link
CN (1) CN117642399A (en)
GB (1) GB202208160D0 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN119841769A (en) * 2025-01-16 2025-04-18 上海凌凯科技股份有限公司 Preparation method, intermediate and application of 1-alkylpyridin-2-ketone compound

Also Published As

Publication number Publication date
CN117642399A (en) 2024-03-01

Similar Documents

Publication Publication Date Title
GB202200735D0 (en) Compounds
GB202303419D0 (en) Compounds
GB202208643D0 (en) Compounds
GB202300021D0 (en) Compounds
GB202214796D0 (en) Compounds
GB202208151D0 (en) Compounds
GB202208160D0 (en) Compounds
GB202201996D0 (en) Compounds
GB202305212D0 (en) Compounds
GB202303387D0 (en) Compounds
GB202303230D0 (en) Compounds
GB202302871D0 (en) Compounds
GB202302237D0 (en) Tryptophan-based compounds
GB202302032D0 (en) Compounds
GB202301024D0 (en) Compounds
GB202301008D0 (en) Compounds
GB202301000D0 (en) Compounds
GB202301012D0 (en) Compounds
GB202300995D0 (en) Compounds
GB202300922D0 (en) Compounds
GB202219706D0 (en) Compounds
GB202219534D0 (en) Compounds
GB202217844D0 (en) Compounds
GB202217330D0 (en) Compounds
GB202216695D0 (en) Compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)